Alan Burnett
Blood Cancer UK(GB)University of Glasgow(GB)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Histone Deacetylase Inhibitors Research, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → Therapeutic Advances in Acute Myeloid Leukemia(2011)778 cited
- → Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia(2012)652 cited
- → Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia(2011)636 cited
- → FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo(2011)257 cited
- → Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML(2024)68 cited
- → Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling(2008)45 cited
- → Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML(1999)38 cited
- → Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia(2014)34 cited
- → Co-Existence of LMPP-Like and GMP-Like Leukemia Stem Cells In Acute Myeloid Leukemia(2010)28 cited
- → Unified classification and risk-stratification in Acute Myeloid Leukemia(2022)24 cited